We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+4.84%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$191B
AUM Growth
+$34.6B
(+22%)
Cap. Flow
+$29.9B
Cap. Flow
% of AUM
15.69%
Top 10 Holdings %
Top 10 Hldgs %
11.5%
Holding
3,667
New
211
Increased
2,098
Reduced
1,163
Closed
105
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Atlassian
TEAM
|
+$905M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$786M |
| 3 |
NVIDIA
NVDA
|
+$736M |
| 4 |
Centene
CNC
|
+$642M |
| 5 |
Apple
AAPL
|
+$451M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Molina Healthcare
MOH
|
+$415M |
| 2 |
Intel
INTC
|
+$329M |
| 3 |
General Motors
GM
|
+$237M |
| 4 |
DoorDash
DASH
|
+$225M |
| 5 |
Intuit
INTU
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.3% |
| 2 | Financials | 15.19% |
| 3 | Healthcare | 12.58% |
| 4 | Consumer Discretionary | 12.42% |
| 5 | Industrials | 12.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3451
SoundThinking
SSTI
$106M
| $117K | ﹤0.01% |
+14,529
| New | +$127K |
|
3452
Fennec Pharmaceuticals
FENC
$444M
| $117K | ﹤0.01% |
15,139
+127
| +0.8% | +$1.04K |
|
|
AXIA.PRC
3453
DELISTED
AXIA Energia American Depositary Shares Preferred Class C
AXIA.PRC
| $114K | ﹤0.01% |
+13,209
| New | +$114K |
|
3454
Clarus
CLAR
$147M
| $113K | ﹤0.01% |
33,739
-17,180
| -34% | -$58.5K |
|
3455
Tronox
TROX
$1.02B
| $112K | ﹤0.01% |
26,961
-170,367
| -86% | -$649K |
|
3456
Crexendo
CXDO
$214M
| $111K | ﹤0.01% |
17,212
+5,390
| +46% | +$35.3K |
|
|
AOMR
3457
Angel Oak Mortgage REIT
AOMR
$208M
| $110K | ﹤0.01% |
12,821
-15,016
| -54% | -$134K |
|
|
AVR
3458
Anteris Technologies
AVR
$894M
| $110K | ﹤0.01% |
21,956
+435
| +2% | +$2K |
|
|
CLPR
3459
Clipper Realty
CLPR
$46.5M
| $109K | ﹤0.01% |
28,554
+1,264
| +5% | +$4.72K |
|
|
SVCO
3460
Silvaco Group
SVCO
$258M
| $109K | ﹤0.01% |
26,797
-14,069
| -34% | -$69.8K |
|
3461
Douglas Elliman
DOUG
$185M
| $108K | ﹤0.01% |
45,780
+28,194
| +160% | +$72.5K |
|
|
STKL
3462
DELISTED
SunOpta
STKL
| $107K | ﹤0.01% |
28,157
-8,922
| -24% | -$40.5K |
|
3463
Codexis
CDXS
$159M
| $105K | ﹤0.01% |
64,675
-19,394
| -23% | -$39.6K |
|
3464
Lifezone Metals
LZM
$373M
| $98.9K | ﹤0.01% |
23,167
-15,049
| -39% | -$68K |
|
3465
Quantum-Si Incorporated
QSI
$179M
| $95.4K | ﹤0.01% |
86,689
+2,865
| +3% | +$4.66K |
|
3466
ImmunityBio
IBRX
$8.07B
| $92.3K | ﹤0.01% |
46,625
-57,154
| -55% | -$129K |
|
3467
Blue Ridge Bankshares
BRBS
$334M
| $91.5K | ﹤0.01% |
21,425
+3,632
| +20% | +$15.8K |
|
3468
Eledon Pharmaceuticals
ELDN
$289M
| $90.9K | ﹤0.01% |
+60,215
| New | +$143K |
|
3469
Biote Corp
BTMD
$46.7M
| $90.1K | ﹤0.01% |
34,672
-30,956
| -47% | -$84.6K |
|
3470
Arena Group
AREN
$75.2M
| $89.7K | ﹤0.01% |
22,421
+10,654
| +91% | +$47.8K |
|
3471
Lucid Diagnostics
LUCD
$184M
| $88.9K | ﹤0.01% |
81,561
+865
| +1% | +$967 |
|
3472
Spire Global
SPIR
$574M
| $84.5K | ﹤0.01% |
+11,262
| New | +$110K |
|
3473
MBIA
MBI
$253M
| $83.3K | ﹤0.01% |
+11,631
| New | +$84.1K |
|
3474
Personalis
PSNL
$1.5B
| $81.5K | ﹤0.01% |
+10,240
| New | +$89.6K |
|
3475
Arbutus Biopharma
ABUS
$923M
| $80.7K | ﹤0.01% |
16,783
+1,550
| +10% | +$6.97K |
|
Similar funds
VGA
AQR Capital Management's Q4 2025 Portfolio in Review
As of Q4 2025, AQR Capital Management held 3,667 positions worth $191B, up 22% from $156B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
AQR Capital Management deployed $29.9B of net new capital in Q4 2025, opening 211 new positions and adding to 2,098 existing holdings. Its largest new stake was Celestica: 1,066,543 shares worth $315M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Molina Healthcare, an estimated $415M trimmed.
- AQR Capital Management's largest Q4 2025 buy was Celestica: 1,066,543 shares worth $315M.
- AQR Capital Management added most to Atlassian in Q4 2025, an estimated $905M increase.
- AQR Capital Management's biggest Q4 2025 reduction was Molina Healthcare, cutting an estimated $415M.
- AQR Capital Management fully exited Light & Wonder in Q4 2025, selling an estimated $70.7M.
- AQR Capital Management's ten largest holdings make up 12% of its $191B portfolio in Q4 2025.
- AQR Capital Management opened 211 new positions and closed 105 in Q4 2025.
- AQR Capital Management's portfolio value rose 22% quarter-over-quarter to $191B.
Based on AQR Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.